USANA Health Sciences, Inc.

USNA Consumer Defensive Packaged Foods

USANA Health Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $925.3 million, up 8.28% from fiscal 2024. In the quarter to June 2026, revenue fell 5.33%, EPS fell 323.1% and free cash flow grew 180.6%, each against the same quarter a year earlier.

15.54 0.16 +1.04%
Market cap
$284.2M
P/E
0.0×
Fwd P/E
14.0×
Dividend yield
—
F-score
7/9
Altman Z
3.59
Beneish M
n/a
Dividend safety
70/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

31.31 35.69 37.17 0.00
P/S ratio
0.55 0.39 0.35 0.43
P/FCF ratio
26.96 29.27 46.49 19.83
P/Operating CF
(257.00) (107.33) 32.94 16.93
P/B ratio
0.95 0.68 0.59 0.75
EV/Sales
0.47 0.29 0.24 0.32
EV/EBITDA
5.51 3.52 3.00 4.37
EV/FCF
22.71 21.84 32.49 14.68
Current Ratio
2.23 2.24 2.51 2.66
Net Debt/EBITDA
(13.47) (11.23) (6.88) (9.21)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
3.19% 2.80% 2.69% (5.67%)
Free Cash Flow Yield
3.71% 3.42% 2.15% 5.04%
Free Cash Flow per Share
(0.28) (0.12) 0.39 1.09
Book value per Share
28.87 28.76 29.54 28.47
Free Cash Flow
(5.16) (2.28) 7.16 20.18
EV/EBIT
10.15 7.25 6.30 0.00
Other line items

Show all line items

Columns are period end dates